Aethlon Medical, Inc. (AEMD )

Currency in USD Disclaimer
$0.58 +$0.15 (33.83%)
Closed 12/20/2024
$0.48
$0.83
$0.24
$2.35

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol AEMD
  • Company Aethlon Medical, Inc.
  • Price $0.58
  • Changes Percentage 33.83
  • Change 0.1466
  • Day Low $0.48
  • Day High $0.83
  • Year High $2.35
  • Year Low $0.24
  • Market Cap $8,097,960
  • Price Avg 50 EMA (D) $0.4
  • Price Avg 200 EMA (D) $0.69
  • Exchange NASDAQ
  • Volume 71,347,596
  • Average Volume 1,243,761
  • Open $0.59
  • Previous Close $0.43
  • EPS -2.79
  • PE -0.21
  • Earnings Announcement 2025-02-12 21:15:00
  • Shares Outstanding $13,962,000

Company brief: AETHLON MEDICAL, INC. (AEMD )

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

AEMD Corporation News

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

December 20, 2024 at 1:01 pm ET

prnewswire.com -- SAN DIEGO , Dec. 20, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, ...

Income Statement